January 30, 2006
Vanderbilt enrolling heart failure patients in new pacing device study
Vanderbilt is one of 40 centers nationwide to enroll patients in a study to determine the efficacy and safety of a new pacing device for heart failure patients. This is the first time the device, called the Optimizer III, will be implanted in humans.
By VUMC News and Communications